Biofilm and Enzyme Formulation
Biofilm consists of microorganisms encased within a self-produced matrix of exopolysaccharides and exoproteins that adheres to interfaces and resists dislodgement. Microorganisms in biofilms are highly resistant to antimicrobials, including antibiotics and bacteriocins produced by probiotics. Ther-Biotic InterFase is a unique enzyme formulation that is specially designed to disrupt the biofilm matrix that embeds gastrointestinal organisms.
Enzymes Included
- Ther-Biotic InterFase
- Enzymes in Ther-Biotic InterFase
- are selected for their ability to lyse the extracellular polymers commonly found in biofilm as well as degrade bacterial and yeast cell wall structures.
- The enzyme blend in Ther-Biotic InterFase was developed using in vitro testing of antibiofilm activity and was found to have significant antibiofilm activity resulting in meaningful degradation of undesirable biofilm communities.
- Ther-Biotic InterFase is intended for use in conjunction with efforts to support normal gastrointestinal function and microbiota.
- As an adjunct, it is best combined with the use of a high-strength, broad-spectrum, multispecies probiotic formulation and a prebiotic to encourage the formation of healthy intestinal microbial biofilm communities.
- Serving Size 1 Capsule
- Amount Per Capsule — % Daily Value
- Proprietary Enzyme Blend — 425 mg
- Providing the following active enzymes:
- Polysaccharide Specific Enzymes
- Glucoamylase (with isomaltase side chain activity)
- Chitosanase
- Cellulase
- Hemicellulase (xylanase) and Pectinase Complex
- Beta-Glucanase
- Protein and Peptide Specific Enzymes
- Protease/Peptidase Complex with endopeptidase, exopeptidase, and DPP-IV activity
- Other Enzymes
- Lysozyme (from egg white)
- Serratia peptididase (from Serratia marcescens) (enteric-coated) (Peptizyme SP)
- Daily value not established
